BRCA2 and prostate carcinoma: In agreement with down-regulated gene expression of BRCA1/2 after loss of LSD1, it has been reported that interference of human LSD1 mRNA by siRNA decreases expression of human BRCA1 and BRCA2 mRNA in LNCaP and C4-2B prostate cancer cell lines based on microarray results53.